K Number
K031034
Date Cleared
2003-05-21

(50 days)

Product Code
Regulation Number
882.5330
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Spin Down RapidFlap is indicated for the re-attachment of the bone flap after a craniotomy.

Device Description
Spin Down RapidFlapmodificationK971252 SevrainCranial ClampK991029 RapidFlapCranial Clamp
Attachment ofupper and lowerplatesThreaded stemattachment betweenthe upper and lowerplatesThreaded stemattachment betweenupper and lower platesGrooved postconnection betweenthe upper and lowerplates.
MaterialCP Titanium andTitanium 6A1 4V alloyCP Titanium, grade 2Titanium 6A1 4V alloy
SterilitySterileNon-SterileSterile
AI/ML Overview

This document describes a medical device modification (Spin Down RapidFlap) and its equivalency to previously cleared devices. It does not contain information about a study proving the device meets acceptance criteria, an AI algorithm, or any associated performance metrics or ground truth establishment.

Therefore, I cannot fulfill your request as it pertains to acceptance criteria, device performance, AI study details, or ground truth. The provided text is a summary of safety and effectiveness for a 510(k) premarket notification for a traditional medical device (a cranial clamp), focusing on its materials and attachment mechanism compared to predicate devices.

{0}------------------------------------------------

MAY 21 2003

K03-1034

page 1 of 1

Summary of Safety and Effectiveness

Device Modification Name: Spin down rapidflap

Name of previously cleared 510(k):Sevrain Cranial Clamp SCC100 - 510(k) K971252
RapidFlap Cranial Clamp - 51k(k) K9910229

Classification Name: Plate, Cranioplasty, Preformed, Non-Alterable

Product Code and Reference: 84 GXN (21 CFR - 882.5330)

Intended use: Spin Down RapidFlap is indicated for the re-attachment of the bone flap after a craniotomy.

Device Modification Description:

Spin Down RapidFlapmodificationK971252 SevrainCranial ClampK991029 RapidFlapCranial Clamp
Attachment ofupper and lowerplatesThreaded stemattachment betweenthe upper and lowerplatesThreaded stemattachment betweenupper and lower platesGrooved postconnection betweenthe upper and lowerplates.
MaterialCP Titanium andTitanium 6A1 4V alloyCP Titanium, grade 2Titanium 6A1 4V alloy
SterilitySterileNon-SterileSterile

Potential Risks:

The potential risks associated with the Spin Down RapidFlap are the same as with the Sevrain Cranial Clamp (K971252), SCC-100 and RapidFlap Cranial Clamp (K991029). The following are contraindicated in the package insert:

    1. Patients with a decompression flap.
    1. Active infection or latent infection.
    1. Patient with insufficient quantity or quality of bone.

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three curved lines representing its body and wings. The eagle is positioned within a circular border that contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in capital letters. The text is arranged around the circumference of the circle.

Public Health Service

MAY 21 2003

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Kim Reed Senior Regulatory Specialist Walter Lorenz Surgical, Inc. 1520 Tradeport Drive Jacksonville, Florida 32218-2480

Re: K031034

Trade/Device Name: Spin Down RapidFlap Regulation Number: 21 CFR 882.5330 Regulation Name: Preformed nonalterable cranioplasty plate Regulatory Class: II Product Code: GXN Dated: March 31, 2003 Received: April 1, 2003

Dear Ms. Reed:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbrarding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{2}------------------------------------------------

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Mark N Milken

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

510(k) Number (if known): (03-103

Spin down rapidflap Device Name:

Indications For Use:

Spin Down RapidFlap is indicated for the re-attachment of the bone flap after a craniotomy.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

for Mark A. Milker
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices

510(k) Number K031034

Prescription Use (Per 21 CFR 801.109) OR

510(k) Number -

Over-The-Counter Use __

(Optional Format 1-2-96)

ﮯ۔

§ 882.5330 Preformed nonalterable cranioplasty plate.

(a)
Identification. A preformed nonalterable cranioplasty plate is a device that is implanted in a patient to repair a skull defect and is constructed of a material, e.g., stainless steel or vitallium, that cannot be altered or reshaped at the time of surgery without changing the chemical behavior of the material.(b)
Classification. Class II (performance standards).